When restricting the exposure ascertainment to codes specific to PCOS only, that is excluding PCO codes, a 37% increased risk of suspected/confirmed COVID-19 was observed among women with PCOS ( n = 8103) compared to their matched controls ( n = 29 711); although, the results did not reach statistical significance (aHR: 1.38 (95% CI: 0.99–1.92), P = 0.056).
← all excerpts
Increased COVID-19 infections in women with polycystic ovary syndrome: a population-based study.
1
0.0560
0.0560